Science Publications

Sign Up
Sign In
Submit
Current Research in Public Health
Cite This Article Share Download PDF XML
  1. Home
  2. Journals
  3. Current Research in Public Health
  4. Archive
  5. Volume 5, Issue 1, 2025
  6. Article
Case Report Open Access December 26, 2024

Propranolol induced Raynaud phenomenon and facial edema in a patient with Hyperthyroidism: A case report

ÇERMA Adishah 1, POSHI Klodiana 2, 3 and TOTI Florian 2, 3
1
Endocrinologist, Regional Hospital of Kukës, Albania
2
University of Medicine, Tirana, Albania
3
Department of Endocrinology, Diabetology and Metabolic Disease, Mother Teresa University Hospital, Tirana, Albania
Publihed in: Current Research in Public Health (Volume 5, Issue 1, 2025)
Page(s): 1-6
DOI: 10.31586/gjmcr.2025.1173
Received
September 16, 2024
Revised
November 26, 2024
Accepted
December 24, 2024
Published
December 26, 2024
Keywords
Propranolol; Raynaud Phenomenon; Facial Edema; Prednisolone
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright: Copyright © The Author(s), 2025. Published by Scientific Publications
Article metrics
Views
497
Downloads
71

Cite This Article

APA Style
Adishah, Ç. , Klodiana, P. , & Florian, T. (2025). Propranolol induced Raynaud phenomenon and facial edema in a patient with Hyperthyroidism: A case report. Current Research in Public Health, 5(1), 1-6. https://doi.org/10.31586/gjmcr.2025.1173
ACS Style
Adishah, Ç. ; Klodiana, P. ; Florian, T. Propranolol induced Raynaud phenomenon and facial edema in a patient with Hyperthyroidism: A case report. Current Research in Public Health 2025 5(1), 1-6. https://doi.org/10.31586/gjmcr.2025.1173
Chicago/Turabian Style
Adishah, ÇERMA, POSHI Klodiana, and TOTI Florian. 2025. "Propranolol induced Raynaud phenomenon and facial edema in a patient with Hyperthyroidism: A case report". Current Research in Public Health 5, no. 1: 1-6. https://doi.org/10.31586/gjmcr.2025.1173
AMA Style
Adishah Ç, Klodiana P, Florian T. Propranolol induced Raynaud phenomenon and facial edema in a patient with Hyperthyroidism: A case report. Current Research in Public Health. 2025; 5(1):1-6. https://doi.org/10.31586/gjmcr.2025.1173 
@Article{crph1173,
AUTHOR = {Adishah, ÇERMA and Klodiana, POSHI and Florian, TOTI},
TITLE = {Propranolol induced Raynaud phenomenon and facial edema in a patient with Hyperthyroidism: A case report},
JOURNAL = {Current Research in Public Health},
VOLUME = {5},
YEAR = {2025},
NUMBER = {1},
PAGES = {1-6},
URL = {https://www.scipublications.com/journal/index.php/GJMCR/article/view/1173},
ISSN = {2831-5162},
DOI = {10.31586/gjmcr.2025.1173},
ABSTRACT = {Background: Propranolol is a non-cardio-selective beta-blocker, commonly used in patients with hyperthyroidism to treat the hyperadrenergic symptoms but also for its additional effect of blocking the peripheral conversion of inactive T4 to active T3. However, propranolol has many side effects, one of them being secondary Raynaud phenomenon. Case presentation: S.K., 55 years old was hospitalized in the Endocrinology Department as an untreated hyperfunctioning goiter with typical clinical manifestations such as fatigue, anxiety, palpitations, heat intolerance, difficulties in swallowing and breathing. Unimazole 5 mg (2-2-2 tb) and Propranolol 40 mg (¼ -0- ¼ tb) were prescribed. Thirty minutes after taking Propranolol (the dose 40 mg), she had difficulties breathing, was agitated, sweating and had nausea. Her face was hyperemic and edematous and her extremities were getting blue and cold. Her vitals remained stable and her airways were opened, as evaluated from laryngoscopy and CT-scan of the neck. 8 hours later, her clinical manifestations got worse: her facial edema spread in her lips and submandibular region. On both cases, she clinically improved after prednisolone administration. 12 hours after taking propranolol, she showed no more signs of cyanosis or edema. Propranolol was replaced by Nebivolol, with no side effects. Conclusion: Secondary Raynaud phenomenon is a common side effect of beta-blockers and should be taken in consideration in very patient presenting with cold and cyanotic peripherals. In these cases, propranolol should be stopped and replaced. Further studies on beta-blockers side effects in patients with hyperthyroidism should be made.},
}
%0 Journal Article
%A Adishah, ÇERMA
%A Klodiana, POSHI
%A Florian, TOTI
%D 2025
%J Current Research in Public Health

%@ 2831-5162
%V 5
%N 1
%P 1-6

%T Propranolol induced Raynaud phenomenon and facial edema in a patient with Hyperthyroidism: A case report
%M doi:10.31586/gjmcr.2025.1173
%U https://www.scipublications.com/journal/index.php/GJMCR/article/view/1173

TY  - JOUR
AU  - Adishah, ÇERMA
AU  - Klodiana, POSHI
AU  - Florian, TOTI
TI  - Propranolol induced Raynaud phenomenon and facial edema in a patient with Hyperthyroidism: A case report
T2  - Current Research in Public Health
PY  - 2025
VL  - 5
IS  - 1
SN  - 2831-5162
SP  - 1
EP  - 6
UR  - https://www.scipublications.com/journal/index.php/GJMCR/article/view/1173
AB  - Background: Propranolol is a non-cardio-selective beta-blocker, commonly used in patients with hyperthyroidism to treat the hyperadrenergic symptoms but also for its additional effect of blocking the peripheral conversion of inactive T4 to active T3. However, propranolol has many side effects, one of them being secondary Raynaud phenomenon. Case presentation: S.K., 55 years old was hospitalized in the Endocrinology Department as an untreated hyperfunctioning goiter with typical clinical manifestations such as fatigue, anxiety, palpitations, heat intolerance, difficulties in swallowing and breathing. Unimazole 5 mg (2-2-2 tb) and Propranolol 40 mg (¼ -0- ¼ tb) were prescribed. Thirty minutes after taking Propranolol (the dose 40 mg), she had difficulties breathing, was agitated, sweating and had nausea. Her face was hyperemic and edematous and her extremities were getting blue and cold. Her vitals remained stable and her airways were opened, as evaluated from laryngoscopy and CT-scan of the neck. 8 hours later, her clinical manifestations got worse: her facial edema spread in her lips and submandibular region. On both cases, she clinically improved after prednisolone administration. 12 hours after taking propranolol, she showed no more signs of cyanosis or edema. Propranolol was replaced by Nebivolol, with no side effects. Conclusion: Secondary Raynaud phenomenon is a common side effect of beta-blockers and should be taken in consideration in very patient presenting with cold and cyanotic peripherals. In these cases, propranolol should be stopped and replaced. Further studies on beta-blockers side effects in patients with hyperthyroidism should be made.
DO  - Propranolol induced Raynaud phenomenon and facial edema in a patient with Hyperthyroidism: A case report
TI  - 10.31586/gjmcr.2025.1173
ER  -